BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kim W, Nam J, Lee S, Jeong S, Jung Y. 5-Aminosalicylic Acid Azo-Linked to Procainamide Acts as an Anticolitic Mutual Prodrug via Additive Inhibition of Nuclear Factor kappaB. Mol Pharm 2016;13:2126-35. [PMID: 27112518 DOI: 10.1021/acs.molpharmaceut.6b00294] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Lee H, Park S, Ju S, Kim S, Yoo JW, Yoon IS, Min DS, Jung Y. Preparation and Evaluation of Colon-Targeted Prodrugs of the Microbial Metabolite 3-Indolepropionic Acid as an Anticolitic Agent. Mol Pharm 2021;18:1730-41. [PMID: 33661643 DOI: 10.1021/acs.molpharmaceut.0c01228] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Ryan A. Azoreductases in drug metabolism. Br J Pharmacol. 2017;174:2161-2173. [PMID: 27487252 DOI: 10.1111/bph.13571] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 4.5] [Reference Citation Analysis]
3 Kim W, Kim D, Jeong S, Ju S, Lee H, Kim S, Yoo JW, Yoon IS, Jung Y. Conjugation of Amisulpride, an Anti-Psychotic Agent, with 5-Aminosalicylic Acid via an Azo Bond Yields an Orally Active Mutual Prodrug against Rat Colitis. Pharmaceutics 2019;11:E585. [PMID: 31703411 DOI: 10.3390/pharmaceutics11110585] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Yang Y, Kim W, Kim D, Jeong S, Yoo JW, Jung Y. A colon-specific prodrug of metoclopramide ameliorates colitis in an experimental rat model. Drug Des Devel Ther 2019;13:231-42. [PMID: 30643389 DOI: 10.2147/DDDT.S185257] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
5 Kim D, Kim W, Jeong S, Kim D, Yoo J, Jung Y. Therapeutic switching of sulpiride, an anti-psychotic and prokinetic drug, to an anti-colitic drug using colon-specific drug delivery. Drug Deliv and Transl Res 2019;9:334-43. [DOI: 10.1007/s13346-018-00599-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
6 Qiao X, Gong Y, Mou Y, Zhang YH, Huang ZJ, Wen XD. Identification of a new azoreductase driven prodrug from bardoxolone methyl and 5-aminosalicylate for the treatment of colitis in mice. Chin J Nat Med 2021;19:545-50. [PMID: 34247779 DOI: 10.1016/S1875-5364(21)60055-9] [Reference Citation Analysis]
7 Kim S, Lee S, Lee H, Ju S, Park S, Kwon D, Yoo JW, Yoon IS, Min DS, Jung YS, Jung Y. A Colon-Targeted Prodrug, 4-Phenylbutyric Acid-Glutamic Acid Conjugate, Ameliorates 2,4-Dinitrobenzenesulfonic Acid-Induced Colitis in Rats. Pharmaceutics 2020;12:E843. [PMID: 32899177 DOI: 10.3390/pharmaceutics12090843] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Ha W, Zhao XB, Zhao WH, Tang JJ, Shi YP. A colon-targeted podophyllotoxin nanoprodrug: synthesis, characterization, and supramolecular hydrogel formation for the drug combination. J Mater Chem B 2021;9:3200-9. [PMID: 33885624 DOI: 10.1039/d0tb02719g] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Kotla NG, Burke O, Pandit A, Rochev Y. An Orally Administrated Hyaluronan Functionalized Polymeric Hybrid Nanoparticle System for Colon-Specific Drug Delivery. Nanomaterials (Basel) 2019;9:E1246. [PMID: 31480704 DOI: 10.3390/nano9091246] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
10 Zhao XB, Ha W, Gao K, Shi YP. Precisely Traceable Drug Delivery of Azoreductase-Responsive Prodrug for Colon Targeting via Multimodal Imaging. Anal Chem 2020;92:9039-47. [PMID: 32501673 DOI: 10.1021/acs.analchem.0c01220] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
11 Jeong S, Lee H, Kim S, Ju S, Kim W, Cho H, Kim HY, Heo G, Im E, Yoo J, Yoon I, Jung Y. 5-Aminosalicylic Acid Azo-Coupled with a GPR109A Agonist Is a Colon-Targeted Anticolitic Codrug with a Reduced Risk of Skin Toxicity. Mol Pharmaceutics 2020;17:167-79. [DOI: 10.1021/acs.molpharmaceut.9b00872] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
12 Ali MS, Farah MA, Al-lohedan HA, Al-anazi KM. Antiproliferative activities of procainamide and its binding with calf thymus DNA through multi-spectroscopic and computational approaches. Journal of Molecular Liquids 2018;258:74-84. [DOI: 10.1016/j.molliq.2018.02.090] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]